What we're about
Advancing prediction, prevention, and precision therapy for patients with rheumatic diseasesWho we are
Over 200 researchers spanning the basic, clinical, and analytical sciencesHow we help
World-class core facilities and investigator support to drive groundbreaking research and launch distinctive careersWhy we care
Patients with rheumatic diseases need better tests and personalized treatments so they can live healthier, longer lives
Recent Publications
- Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation January 18, 2023
- Genetic load in incomplete lupus erythematosus January 4, 2023
- Dysregulated long non-coding RNA in Sjögren's disease impacts both interferon and adaptive immune responses December 1, 2022
- A Flare Risk Index Informed by Select Immune Mediators in Systemic Lupus Erythematosus October 17, 2022
- The promise of precision medicine in rheumatology July 5, 2022
- Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals June 20, 2022
- Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus June 20, 2022